Coronary Artery Calcium and Polygenic Risk Scores For Cardiovascular Risk Prediction: Results From Two Population-Based Studies
- Study Overview: The study compared the effectiveness of the coronary artery calcium (CAC) score and polygenic risk scores (PRS) in predicting coronary heart disease (CHD) risk.
- Key Findings: The CAC score outperformed PRS in risk discrimination and reclassification when added to traditional risk factors.
- Clinical Implications: The CAC score appears to be a more reliable tool for guiding preventive therapies in middle-aged and older adults however combining CAC scores with PRS and other technologies may enhance early risk stratification, especially in younger individuals.
In the realm of cardiovascular disease prevention, two significant markers are often discussed: Coronary Artery Calcium (CAC) and Polygenic Risk Scores (PRS). Here’s a look at the recent study comparing these two markers and what the findings mean for patients.
What is CAC?
CAC is a measure of the amount of calcium in the walls of the coronary arteries, which supply blood to the heart muscle. It’s detected through a CT scan and quantified with a score. A higher CAC score indicates a higher risk of heart disease because it reflects more extensive atherosclerotic plaque buildup.
What is PRS?
PRS, on the other hand, is a relatively new approach that involves calculating an individual’s genetic predisposition to a disease based on the presence of multiple genetic variants. Each variant contributes a small amount to the overall risk, and when combined, they can provide a score that estimates genetic risk for diseases like coronary heart disease (CHD).
The study, published in the American College of Cardiology Journal compared the predictive power of CAC and PRS for coronary heart disease. It found that the CAC score was superior in risk discrimination and reclassification when added to traditional risk factors such as age, cholesterol levels, and blood pressure.
For patients, this means that the CAC score can be a more reliable indicator of their risk for CHD compared to PRS. This is particularly true for middle-aged and older adults, for whom the CAC score can guide decisions about preventive therapies like statins.
However, the study also suggests that PRS has potential, especially when used alongside other risk prediction tools. For younger individuals, who may not yet show a high CAC score, PRS could help identify a genetic predisposition to CHD early on.
In clinical practice, the results of this study could lead to more personalized approaches to cardiovascular disease prevention. By combining CAC scores with PRS and other technologies, healthcare providers can enhance early risk stratification and tailor preventive strategies to the individual patient.
While CAC remains a cornerstone in cardiovascular risk assessment, the integration of PRS could refine our understanding of CHD risk and prevention, especially in younger patients and ultimately lead to better patient outcomes. The study’s findings are a step forward in the journey toward personalized medicine in cardiology.
Follow us on Facebook to keep up with new developments in treating cardiovascular disease.
Check your eligibility to participate in one of NHI’s clinical trials at https://nationalheartinstitute.org/clinical-trials
